Cite

HARVARD Citation

    Shen, L. et al. (2022). Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity. Cancer letters. p. . [Online]. 
  
Back to record